Effects of Licorice in treatment of COVID-19

Phase 3

Recruiting

Conditions: COVID-19 disease.
COVID-19, virus not identified
U07.2

Registration Number: IRCT20200506047323N2

Lead Sponsor: Bandare-abbas University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 60

Inclusion Criteria

Age =18 years
Positive polymerase chain reaction (PCR) test for COVID-19 or/and lung involvement in imaging
Primary clinical symptoms
Hospitalized
Signing informed consent and willingness of study participant to accept randomization to any assigned treatment arm

Exclusion Criteria

Underlying diseases (heart disease, chronic hypertension, severe renal failure, severe liver failure, and thyroid disorders)
Use of warfarin, SSRIs, MAOIs, diuretics, corticosteroids, and antiarrhythmic drugs
History of drug allergy
Pregnancy and breastfeeding

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Body temperature. Timepoint: Before intervention and daily during the study. Method of measurement: Thermometer.;Respiratory rate. Timepoint: Before intervention and daily during the study. Method of measurement: Respiratory Count.;Oxygen saturation. Timepoint: Before intervention and daily during the study. Method of measurement: Pulse oximeter.

Secondary Outcome Measures

Name	Time	Method
ymphocytopenia. Timepoint: Before intervention and days 7 and 14 after the intervention. Method of measurement: Cell count.;C-reactive protein. Timepoint: Before intervention and days 7 and 14 after the intervention. Method of measurement: C-RP kit.;Incidence of serious adverse events. Timepoint: Before intervention and daily during the study. Method of measurement: Questionnaire.